Determinants of Sickness Absence Duration After Mild COVID-19 in a Prospective Cohort of Canadian Healthcare Workers.
Journal
Journal of occupational and environmental medicine
ISSN: 1536-5948
Titre abrégé: J Occup Environ Med
Pays: United States
ID NLM: 9504688
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
medline:
6
11
2023
pubmed:
17
8
2023
entrez:
17
8
2023
Statut:
ppublish
Résumé
The aim of the study is to identify modifiable factors associated with sickness absence duration after a COVID-19 infection. Participants in a prospective cohort of 4964 Canadian healthcare workers were asked how many working days they had missed after a positive COVID-19 test. Only completed episodes with absence ≤31 working day and no hospital admission were included. Cox regression estimated the contribution of administrative guidelines, vaccinations, work factors, personal characteristics, and symptom severity. A total of 1520 episodes of COVID-19 were reported by 1454 participants. Days off work reduced as the pandemic progressed and were fewer with increasing numbers of vaccines received. Time-off was longer with greater symptom severity and shorter where there was a provision for callback with clinical necessity. Vaccination, an important modifiable factor, related to shorter sickness absence. Provision to recall workers at time of clinical need reduced absence duration.
Identifiants
pubmed: 37590394
doi: 10.1097/JOM.0000000000002945
pii: 00043764-202311000-00009
pmc: PMC10662618
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
958-966Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Occupational and Environmental Medicine.
Déclaration de conflit d'intérêts
Conflict of interest: Q.D.-M received honorarium provided by the University of Saskatchewan for grant review.
Références
Van der Plaat DA, Edge R, Coggon D, et al. Impact of COVID-19 pandemic on sickness absence for mental ill health in National Health Service staff. BMJ Open 2021;11:e054533.
de Paiva LG, Dos Santos WM, de Lima Dalmolin G. The impact of the SARS-CoV-2 pandemic on sickness absenteeism among hospital workers. Rev Bras Med Trab 2022;20:65–71.
Skyrud K, Telle K, Magnusson K. Impacts of mild and severe COVID-19 on sick leave. Int J Epidemiol 2021;50:1745–1747.
Westerlind E, Palstam A, Sunnerhagen KS, Persson HC. Patterns and predictors of sick leave after COVID-19 and long COVID in a national Swedish cohort. BMC Public Health 2021;21:1023.
Jacobsen PA, Andersen MP, Gislason G, et al. Return to work after COVID-19 infection—a Danish nationwide registry study. Public Health 2022;203:116–122.
Hajek A, König HH. Personality-related and psychosocial correlates of sick leave days in Germany during the COVID-19 pandemic: findings of a representative survey. Arch Public Health 2022;80:227.
Aben B, Kok RN, de Wind A. Return-to-work rates and predictors of absence duration after COVID-19 over the course of the pandemic. Scand J Work Environ Health 2023;49:182–192. doi:10.5271/sjweh.4077.
doi: 10.5271/sjweh.4077
van der Plaat DA, Madan I, Coggon D, et al. Risks of COVID-19 by occupation in NHS workers in England. Occup Environ Med 2022;79:176–183.
Reme BA, Grøsland M, Gjefsen H, Magnusson K. Impact of the COVID-19 pandemic on sick leave among healthcare workers: a register-based observational study. Occup Environ Med 2023;80:319–325.
Kisiel MA, Nordqvist T, Westman G, Svartengren M, Malinovschi A, Janols H. Patterns and predictors of sick leave among Swedish non-hospitalized healthcare and residential care workers with COVID-19 during the early phase of the pandemic. PloS One 2021;16:e0260652.
Silberner J. COVID-19: North Dakota and Belgium have let infected health staff work on wards. BMJ 2020;371:m4455.
United States Centers for Disease Control and Prevention. Strategies to mitigate healthcare personnel staffing shortages. Available at: https://stacks.cdc.gov/view/cdc/88616/cdc_88616_DS1.pdf . Accessed April 26, 2023.
European Centre for Disease Prevention and Control. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Guidance-for-discharge-and-ending-of-isolation-of-people-with-COVID-19-third-update.pdf . Accessed April 25 2023.
Cherry N, Adisesh A, Burstyn I, Durand-Moreau Q, Galarneau J-M, Labrèche F, Ruzycki S, Zadunayski T. Cohort profile: recruitment and retention in a prospective cohort of Canadian health care workers during the COVID-19 pandemic Under review BMJ Open doi: 10.1101/2023.04.14.23288575. Accessed April 26, 2023.
doi: 10.1101/2023.04.14.23288575
Cherry N, Mhonde T, Adisesh A, et al. The evolution of workplace risk for COVID-19 in Canadian healthcare workers and its relation to vaccination: a nested case-referent study. Am J Ind Med 2023;66:297–306.
Lamping DL, Schroter S, Marquis P, Marrel A, Duprat-Lomon I, Sagnier PP. The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest 2002;122:920–929.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69–77.
Eisen D. Employee presenteeism and occupational acquisition of COVID-19. Med J Aust 2020;213:140–140.e1.
Webster RK, Liu R, Karimullina K, Hall I, Amlôt R, Rubin GJ. A systematic review of infectious illness presenteeism: prevalence, reasons and risk factors. BMC Public Health 2019;19:799.
Jung J, Kang SW, Lee S, et al. Risk of transmission of COVID-19 from healthcare workers returning to work after a 5-day isolation, and kinetics of shedding of viable SARS-CoV-2 variant B.1.1.529 (Omicron). J Hosp Infect 2023;131:228–233.
Raza M, Giri P, Basu S. Surveillance and return to work of healthcare workers following SARS-CoV-2 Omicron variant infection, Sheffield, England, 17 January to 7 February 2022. Euro Surveill 2022;27:2200164.
Kolodziej LM, Hordijk S, Koopsen J, et al. Risk of SARS-CoV-2 transmission upon return to work in RNA-positive healthcare workers. J Hosp Infect 2022;124:72–78.
Sakr CJ, Fakih L, Melhem NM, et al. COVID-19 infections and predictors of sickness related absences among healthcare workers: the experience of a tertiary care center with the COVID-19 pandemic. J Occup Environ Med 2023;65:590–594.
Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. Lancet Public Health 2020;5:e375–e385.
Aguilar E, Roberts NJ, Uluturk I, et al. Adaptive staffing can mitigate essential worker disease and absenteeism in an emerging epidemic. Proc Natl Acad Sci U S A 2021;118:e2105337118.
Thompson MG, Burgess JL, Naleway AL, et al. Prevention and attenuation of COVID-19 with the BNT162b2 and mRNA-1273 vaccines. N Engl J Med 2021;385:320–329.
Prato' S, Paladino ME, Riva MA, Belingheri M. COVID-19 vaccination and asymptomatic infection: effect of BNT162b2 mRNA vaccine on the incidence of COVID-19 and duration of sick leave among healthcare workers. J Occup Environ Med 2021;63:e868–e870.